Former Genentech execs — including ex-CEO Ian Clark — jump in with IPO-seeking gene therapy company
By Gomez in Business
Updated 3 years ago
The company, with sites in the Bay Area, Philadelphia and London, also counts Genentech and a handful of other local biotechs as its competition.
